Abstract
Fenofibrate (isopropyl 4-(p-chlorobenzoyl)phenoxyisobutyrate: Lipanthyl) is a hypolipidaemic agent structurally related to Clofibrate. In view of current concern over the safety-in-use of this class of drug, there is a need for information about their metabolic disposition, in terms of rates and routes of metabolism and excretion and various factors which might influence these, such as species differences, chronic administration and dose dependency. As an adjunct to both the toxicological evaluation and clinical pharmacological investigation of fenofibrate, we now present the results of a study of its fate in rat, dog and man, and some potential influencing factors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Caldwell J (1985) Glucuronic acid conjugation in the context of the metabolic conjugation of xenobiotics. In: Matern S, Bock KW, Gerok W (eds) Advance in Glucuronide Conjugation. MTP, Lancaster, UK, pp 7–20
Caldwell J, Hutt AJ (1986) Methodology for the isolation and characterization of conjugates of xenobiotic carboxylic acids. In: Bridges JW, Chasseaud LF (eds) Progress in Drug Metabolism, vol 9. Taylor and Francis, London, pp 11–51
Emudianughe TS, Caldwell J, Sinclair KA, Smith RL (1983) Species differences in the metabolic conjugation of clofibric acid and Clofibrate in laboratory animals and man. Drug Metab Dispos 11:97–102
Hutt AJ, Fournel S, Caldwell J (1986) The application of a radial compression column to the high performance liquid chromatographic separation of the enantiomers of some 2-arylpropionic acids as their diastereoisomeric R-(+)-1-[naphthen-1-yl]ethylamides. J Chrom 378:409–418
Sangster SA, Caldwell J, Hutt AJ, Smith RL (1983) The metabolism of p-propylanisole in the rat and mouse and its variation with dose. Fd Chem Toxicol 21:263–271
Sinclair KA, Caldwell J (1982) The formation of β-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates. Biochem Pharmacol 31:953–957
Van Breemen R, Fenselau C (1985) Acylation of albumin by 1-O-acyl glucuronides. Drug Metab Dispos 13:318–320
Van der Waterbeemd H, Testa B, Caldwell J (1986) The influence of conformational factors on the metabolic conjugation of aryloxyacetates. J Pharm Pharmacol 38:14–18
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Weil, A., Caldwell, J., Strolin-Benedetti, M., Dostert, P. (1987). Species Differences in the Metabolic Disposition of Fenofibrate. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_60
Download citation
DOI: https://doi.org/10.1007/978-3-642-71702-4_60
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71704-8
Online ISBN: 978-3-642-71702-4
eBook Packages: Springer Book Archive